Form 4 for AMGN Amgen
Accepted 2025-02-10 00:00:00 ET · period of report 2025-02-07 · accession 0001127602-25-003984 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-02-10 | 2025-02-07 | AMGN | Graham Jonathan P | EVP, Gen. Counsel, Secy | M - OptEx | $156.35 | +25.0K | 54.0K | +86% | +$3.92M |
| D | 2025-02-10 | 2025-02-07 | AMGN | Graham Jonathan P | EVP, Gen. Counsel, Secy | S - Sale+OE | $293.12 | -25.0K | 29.0K | -46% | -$7.34M |
| D | 2025-02-10 | 2025-02-07 | AMGN | Graham Jonathan P | EVP, Gen. Counsel, Secy | M - OptEx | $0.00 | -25.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-07 | M | A | 25,045 | $156.35 | 54,032 | D | — | — | (F1) These shares were acquired in connection with the exercise of stock options expiring on May 3, 2026. |
| 2 | Common | Common Stock | 2025-02-07 | S | D | 25,045 | $293.12 | 28,987 | D | — | — | (F2) The price reported is an average price. Full information regarding the number of shares sold at each separate price is available upon request by the SEC staff, the issuer or a security holder of the issuer. (F3) These shares include 634 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. |
| 3 | Derivative | Nqso (Right to Buy) | 2025-02-07 | M | D | 25,045 | $0.00 | 0 | D | $156.35 · 2018-05-03 to 2026-05-03 | 25,045 Common Stock |